Business Segments Bayer AG

Equities

Market Closed - Xetra Other stock markets 09:05:26 09/07/2025 pm IST			After hours 10:09:42 pm
27.33 ^EUR	+0.55%		27.33	0.00%

04:31pm	Health Rounds: Experimental Bayer drug eases menopause-like symptoms from breast cancer therapy	RE
11:11am	Bayer Wins Maiden Approval For Menopausal Hot Flashes Medication From UK Regulator	MT

See more © MarketScreener.com

See more © MarketScreener.com

Breakdown by Business Segment (EUR)

Fiscal Period: December	2020	2021	2022	2023	2024
Nitrogenous Fertilizers
Crop Science	1.88TCr	2.02TCr	2.52TCr	2.33TCr	2.23TCr
Total Assets	-	-	-	-	-
CAPEX	-131.7Cr	-124Cr	-178.6Cr	-160.1Cr	-145.1Cr
EBITDA	453.6Cr	469.8Cr	686.7Cr	503.8Cr	432.5Cr
D&A	269.4Cr	225.7Cr	459.6Cr	237.2Cr	246.6Cr
Operating Income	179.1Cr	-50Cr	295Cr	-348.6Cr	-275.6Cr
Pharmaceutical Products
Pharmaceuticals	1.73TCr	1.84TCr	1.93TCr	1.81TCr	1.82TCr
Total Assets	-	-	-	-	-
CAPEX	-138.6Cr	-130.8Cr	-131.7Cr	-121.2Cr	-129.3Cr
EBITDA	601.6Cr	577.9Cr	587.3Cr	518.9Cr	472.2Cr
D&A	95Cr	87Cr	122.7Cr	91Cr	94Cr
Operating Income	503.2Cr	446.9Cr	498.5Cr	397.1Cr	279Cr
Non-Prescription Drugs
Consumer Health	505.4Cr	529.3Cr	608Cr	603.4Cr	587.5Cr
Total Assets	-	-	-	-	-
CAPEX	-17Cr	-21Cr	-20Cr	-17Cr	-21Cr
EBITDA	111.4Cr	119Cr	136.7Cr	141.1Cr	136.6Cr
D&A	32Cr	33Cr	36Cr	36Cr	38Cr
Operating Income	79Cr	81Cr	96Cr	115.8Cr	102.8Cr
Outsourced Business Services
All Other	37Cr	20Cr	22Cr	24Cr	33Cr
Total Assets	-	-	-	-	-
CAPEX	-6.6Cr	-9.3Cr	-4.3Cr	-10Cr	-7.1Cr
EBITDA	18Cr	9.5Cr	15Cr	16Cr	6.2Cr
D&A	6.9Cr	6.9Cr	7.1Cr	6.7Cr	7.2Cr
Operating Income	-	-2.7Cr	7.9Cr	9.6Cr	-1.1Cr
Enabling Functions and Consolidation	-16Cr	-50L	-10L	-3.6Cr	-7.2Cr
Total Assets	-	-	-	-	-
CAPEX	-20Cr	-16Cr	-29Cr	-24Cr	-24Cr
EBITDA	-38Cr	-58Cr	-74Cr	-9.5Cr	-35Cr
D&A	25Cr	21Cr	24Cr	20Cr	20Cr
Operating Income	-63Cr	-140.2Cr	-195.9Cr	-112.7Cr	-112.2Cr
Total Assets	-	-	-	-	-
Plastic and Synthetic Resins
Covestro	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
EBITDA	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
Veterinary Drugs
Animal Health	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
EBITDA	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-

Geographical breakdown of sales (EUR)

Fiscal Period: December	2020	2021	2022	2023	2024
United States	1.29TCr	1.34TCr	1.57TCr	1.46TCr	1.48TCr
Total Assets	4.34TCr	4.8TCr	4.62TCr	3.95TCr	3.71TCr
Europe / Middle East / Africa (Excl. Germany & Switzerland)	1TCr	1.06TCr	1.14TCr	1.11TCr	1.1TCr
Total Assets	396.8Cr	428.5Cr	479.2Cr	445.8Cr	416Cr
Asia / Pacific (Excl.China)	478.4Cr	499.3Cr	519.2Cr	474.5Cr	447.1Cr
Total Assets	132.5Cr	130.7Cr	120.3Cr	97Cr	86Cr
Brazil	299.4Cr	347.6Cr	532.2Cr	496.7Cr	431.7Cr
Total Assets	165.3Cr	163.2Cr	183.6Cr	146.6Cr	107Cr
Latin America (Excl. Brazil)	290.6Cr	315.6Cr	396.6Cr	396.1Cr	376.1Cr
Total Assets	102.3Cr	122.4Cr	143.8Cr	129.5Cr	133.8Cr
China	348.3Cr	385.6Cr	425.9Cr	362.4Cr	360Cr
Total Assets	59Cr	62Cr	68Cr	70Cr	58Cr
Germany	236.1Cr	254.5Cr	247.7Cr	244.8Cr	241Cr
Total Assets	1.53TCr	1.55TCr	1.52TCr	1.52TCr	1.51TCr
North America (Excl.United States)	146.7Cr	155.5Cr	188.6Cr	166.7Cr	168.1Cr
Total Assets	142.3Cr	158.3Cr	148.4Cr	106.3Cr	89Cr
Switzerland	50Cr	54Cr	60Cr	57Cr	58Cr
Total Assets	511.9Cr	493.3Cr	466.5Cr	432.4Cr	442.8Cr
Europe / Middle East / Africa	-	-	-	-	-
D&A	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
Operating Income	-	-	-	-	-
Latin America	-	-	-	-	-
D&A	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
Operating Income	-	-	-	-	-
Latin America / Africa / Middle East	-	-	-	-	-
D&A	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
Operating Income	-	-	-	-	-
Asia / Pacific	-	-	-	-	-
D&A	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
Operating Income	-	-	-	-	-
Reconciliation	-	-	-	-	-
D&A	-	-	-	-	-
Total Assets	-	-	-	-	-
Operating Income	-	-	-	-	-
North America	-	-	-	-	-
D&A	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
Operating Income	-	-	-	-	-
Europe	-	-	-	-	-
D&A	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
Operating Income	-	-	-	-	-